DE VINCENTIS, ANTONIO
 Distribuzione geografica
Continente #
AS - Asia 5.722
NA - Nord America 2.225
EU - Europa 959
SA - Sud America 310
Continente sconosciuto - Info sul continente non disponibili 80
AF - Africa 48
OC - Oceania 11
Totale 9.355
Nazione #
SG - Singapore 4.277
US - Stati Uniti d'America 2.130
CN - Cina 601
IT - Italia 522
HK - Hong Kong 279
BD - Bangladesh 236
BR - Brasile 212
VN - Vietnam 127
FR - Francia 114
GB - Regno Unito 102
DE - Germania 67
IN - India 52
CA - Canada 43
AR - Argentina 35
MX - Messico 34
NL - Olanda 29
TR - Turchia 23
FI - Finlandia 19
ID - Indonesia 18
PL - Polonia 18
CZ - Repubblica Ceca 17
EC - Ecuador 17
JP - Giappone 17
CO - Colombia 14
ZA - Sudafrica 14
VE - Venezuela 13
UA - Ucraina 12
IQ - Iraq 11
AU - Australia 10
EG - Egitto 10
SA - Arabia Saudita 10
KE - Kenya 9
MY - Malesia 9
PK - Pakistan 9
PH - Filippine 8
PT - Portogallo 8
ES - Italia 7
RO - Romania 7
RU - Federazione Russa 7
CL - Cile 6
NP - Nepal 6
PE - Perù 6
CR - Costa Rica 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
HN - Honduras 4
IE - Irlanda 4
CH - Svizzera 3
KR - Corea 3
LB - Libano 3
LT - Lituania 3
MD - Moldavia 3
PY - Paraguay 3
SE - Svezia 3
TN - Tunisia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AT - Austria 2
AZ - Azerbaigian 2
BH - Bahrain 2
BY - Bielorussia 2
DZ - Algeria 2
ET - Etiopia 2
IR - Iran 2
JM - Giamaica 2
JO - Giordania 2
KZ - Kazakistan 2
RS - Serbia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
BE - Belgio 1
BF - Burkina Faso 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CY - Cipro 1
FK - Isole Falkland (Malvinas) 1
GN - Guinea 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
KH - Cambogia 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MA - Marocco 1
MS - Montserrat 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
SV - El Salvador 1
Totale 9.273
Città #
San Jose 577
Singapore 437
Ashburn 369
Rome 328
Hong Kong 276
Hefei 183
Beijing 175
Council Bluffs 127
Columbus 100
Boardman 91
Dallas 88
Lauterbourg 88
London 67
Shanghai 63
Santa Clara 60
Los Angeles 56
New York 53
Ho Chi Minh City 49
Munich 39
Mexico City 30
Hanoi 27
Chicago 22
Buffalo 21
Phoenix 20
Amsterdam 18
Milan 18
San Francisco 18
São Paulo 18
Brno 16
Orem 15
Turku 15
Boston 14
Pune 13
Seattle 13
Tokyo 13
Paris 12
Toronto 12
Warsaw 12
Montreal 11
Washington 11
Brooklyn 10
Naples 10
Las Vegas 9
Chennai 8
Lisbon 8
Manchester 8
Nairobi 8
Rio de Janeiro 8
Boydton 7
Cairo 7
Charlotte 7
Haiphong 7
Redmond 7
Turin 7
Frankfurt am Main 6
Guangzhou 6
Guayaquil 6
Istanbul 6
Johannesburg 6
Pasadena 6
Quito 6
Bucharest 5
Canberra 5
Lahore 5
Miami 5
Riyadh 5
Barquisimeto 4
Bologna 4
Buenos Aires 4
Curitiba 4
Da Nang 4
Hangzhou 4
Helsinki 4
Houston 4
Kochi 4
Melbourne 4
New Delhi 4
Philadelphia 4
Poplar 4
Tashkent 4
Trieste 4
Ascoli Piceno 3
Atlanta 3
Bari 3
Bedford 3
Belo Horizonte 3
Birmingham 3
Bogotá 3
Campinas 3
Caracas 3
Curvelo 3
Denver 3
Detroit 3
Dublin 3
Genoa 3
Goiânia 3
Helena 3
Jakarta 3
Jeddah 3
José C. Paz 3
Totale 3.870
Nome #
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 252
A Functional and Immunologic Point of View on Corneal Endothelial Transplantation: A Systematic Review and Meta-Analysis 241
Management of hip fracture in the older people: rationale and design of the Italian consensus on the orthogeriatric co-management 241
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 239
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 237
Chronic cough in adults: recommendations from an Italian intersociety consensus 232
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 221
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 220
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 216
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 211
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 209
Assessment of liver function by the exhaled breath-print during chronic liver disease 207
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 201
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 175
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 174
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 156
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 147
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 143
Exhaled breath analysis in hepatology: State-of-the-art and perspectives 141
Orthogeriatric co-management for the care of older subjects with hip fracture: recommendations from an Italian intersociety consensus 141
Return to Sport after Anatomic and Reverse Total Shoulder Arthroplasty in Elderly Patients: A Systematic Review and Meta-Analysis 137
A challenging alfa-fetoprotein in a cirrhotic patient 136
Gut Microbiota and Related Electronic Multisensorial System Changes in Subjects With Symptomatic Uncomplicated Diverticular Disease Undergoing Rifaximin Therapy 135
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 134
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease 133
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 127
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease 125
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 122
Appropriateness of direct oral anticoagulant prescribing in older subjects with atrial fibrillation discharged from acute medical wards 119
Authors' Reply to Brunetti et al. "Potentially Inappropriate Medications, Drug-Drug Interactions, and Anticholinergic Burden in Elderly Hospitalized Patients: Does an Association Exist with Post-Discharge Health Outcomes?" 119
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 116
ALT levels are associated with metabolic parameters and age in a large real-life population. 115
Breathprinting of liver diseases 115
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon 114
Analysis of volatile organic compounds: an innovative approach to heart failure characterization in older patients 114
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores 110
Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient 107
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 103
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 97
Essays on quality of therapy and impact of comorbidities in older hospitalized subjects 93
Prevalence, risk factors, and treatment of anemia in hospitalized older patients across geriatric and nephrological settings in Italy 92
Clinical outcomes and phenotypes of respiratory failure in older subjects admitted to an acute care geriatric hospital ward 89
Length of Hospital Stay after Total Knee Arthroplasty: A Correlation Study on 1200 Patients 77
Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease 75
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 74
Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis 74
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients 73
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management 70
Potentially inappropriate medications, drug–drug interactions, and anticholinergic burden in elderly hospitalized patients: does an association exist with post-discharge health outcomes? 68
Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population 65
Prevalence, clinical characteristics, and disease burden of chronic cough in Italy: a cross-sectional study 65
Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian survey 65
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank 65
Incidence and Outcome of Pneumomediastinum in Non-ICU Hospitalized COVID-19 Patients 65
Low Alanine Aminotransferase Levels in the Elderly Population: Frailty, Disability, Sarcopenia, and Reduced Survival 64
Return to Sport Activity in the Elderly Patients after Unicompartmental Knee Arthroplasty: A Systematic Review and Meta-Analysis 63
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 62
Correction: Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian survey 62
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 61
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease 60
Impact of Low Muscle Mass and Low Muscle Strength According to EWGSOP2 and EWGSOP1 in Community-Dwelling Older People 58
Reply to the Letter: “Low levels of transaminase and mortality risk in older people with special reference to sarcopenia” 58
Hepatic complications of bariatric surgery : the reverse side of the coin 57
Rate of non-response to ursodeoxycholic acid in a large real-world cohort of primary biliary cholangitis patients in Italy 57
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 55
Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis 53
Preoperative and Perioperative Predictors of Length of Hospital Stay after Primary Total Hip Arthroplasty-Our Experience on 743 Cases 53
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 52
NAFLD FIBROSIS SCORE IS ASSOCIATED WITH CARDIOVASCULAR DISEASE IN PATIENTS UNDERGOING CORONAROGRAPHY 52
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 51
Individuation of presence and combination of genetic risk factors may help to refine the risk for most severe forms of NAFLD 51
Microarray-based Detection of Critical Overexpressed Genes in the Progression of Hepatic Fibrosis in Non-alcoholic Fatty Liver Disease: A Protein-protein Interaction Network Analysis 50
Effect of sibutramine on plasma C-reactive protein, leptin and adiponectin concentrations: a systematic review and meta-analysis of randomized controlled trials 50
Predicting risk of declining functional ability in community-dwelling older people 49
E-nose discriminative ability within a highly homogeneous sample of respiratory diseases 49
Sleep disorders during the COVID-19 pandemic: Results from the second phase of web-based EPICOVID19 study 48
Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD) 48
Screening of obstructive sleep apnea syndrome by electronic-nose analysis of volatile organic compounds 48
Voltammetric analysis for distinguishing portal hypertension-related from malignancy-related ascites: A proof of concept study 48
Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liver 47
Inborn and acquired risk factors for severe liver disease in Europeans with type 2 diabetes from the UK Biobank 46
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry 44
Neurotrophic keratopathy: pros and cons of current treatments 44
Genetic variants in the MTHFR are not associated with fatty liver disease. 43
The authors reply 43
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 41
Platelet count may impact on lysosomal acid lipase activity determination in dried blood spot 41
Reply 40
Long noncoding RNAs in nonalcoholic fatty liver disease and liver fibrosis: state-of-the-art and perspectives in diagnosis and treatment 40
Liver Cirrhosis is Characterized by an Acquired Lysosomal Acid Lipase Deficiency Independent from the Etiology of Liver Disease 39
A noninvasive strategy for multi-disease diagnosis via multi-sensor platform: integrative analysis of five years of exhaled breath-based diagnostics for seven diseases 36
Prevalence of anti-hepatitis C positivity in a nursing home: a hitherto unrecognized submerged population 33
Reply 32
Prevalence of patatin-like phospholipase domain containing 3 (PNPLA3) rs738409 C/G polymorphism in patients with bona-fide post-NASH cirrhosis 32
PhenoAge and PhenoAgeAccel do not outperform chronological age in predicting physical performance decline or mortality in community-dwelling older adults 3
Totale 9.355
Categoria #
all - tutte 49.723
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.723


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022174 0 0 10 0 1 4 0 2 54 0 0 103
2022/202399 1 1 8 2 10 4 36 9 5 7 16 0
2023/2024316 11 27 15 36 39 120 0 10 4 16 12 26
2024/20254.616 57 25 87 19 75 96 87 25 217 291 1.633 2.004
2025/20263.688 295 148 222 344 132 202 956 214 252 329 307 287
2026/2027462 60 340 62 0 0 0 0 0 0 0 0 0
Totale 9.355